Literature DB >> 17237995

Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.

Yeon Seok Seo1, Jong-Jae Park, Ji Hoon Kim, Jin Yong Kim, Jong Eun Yeon, Jae Seon Kim, Kwan Soo Byun, Young-Tae Bak.   

Abstract

Degradation of the extracellular matrix is an essential step in tumor invasion and metastasis. It involves the actions of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). We evaluated the expression of MMP-9 and TIMP-1 in gastric carcinomas and the relationship between this expression and tumor recurrence. Eighty patients who had undergone curative surgical resection for gastric carcinoma were included. Resected gastric tissue samples were stained immunohistochemically to evaluate the expression of MMP-9 and TIMP-1. TIMP-1 expression was related to the depth of tumor invasion and lymph node metastasis. The proportion of tumors larger than 5 cm, or displaying muscle layer invasion, and the cumulative incidence of tumor recurrence were significantly elevated in patients with tumors expressing TIMP-1. Furthermore, these measures were lowest in patients with no TIMP-1 expression and highest in patients who only expressed TIMP-1. In conclusion, TIMP-1 expression and the balance between expression of MMP-9 and expression of TIMP-1 may be important indicators of tumor progression and predictors of tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237995     DOI: 10.1007/s10620-006-9535-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  23 in total

1.  Re-study of gastric cancer: analysis of outcome.

Authors:  Prudencio S Samson; Laurence Anthony P Escovidal; Samuel G Yrastorza; Ronaldo G Veneracion; Mary Yvonnette C Nerves
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

2.  Cancer statistics, 1997.

Authors:  S L Parker; T Tong; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1997 Jan-Feb       Impact factor: 508.702

Review 3.  Computational sequence analysis of the tissue inhibitor of metalloproteinase family.

Authors:  D A Douglas; Y E Shi; Q A Sang
Journal:  J Protein Chem       Date:  1997-05

4.  Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma. A possible marker for serosal invasion and metastasis.

Authors:  T Yoshikawa; M Saitoh; A Tsuburaya; O Kobayashi; M Sairenji; H Motohashi; S Yanoma; Y Noguchi
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

Review 5.  Molecular-pathological prognostic factors of gastric cancer: a review.

Authors:  Wataru Yasui; Naohide Oue; Phyu Phyu Aung; Shunji Matsumura; Mariko Shutoh; Hirofumi Nakayama
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

6.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

7.  Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer.

Authors:  T Yoshikawa; A Tsuburaya; O Kobayashi; M Sairenji; H Motohashi; S Yanoma; Y Noguchi
Journal:  Cancer Lett       Date:  2000-04-03       Impact factor: 8.679

8.  Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization.

Authors:  A H Boag; I D Young
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

9.  Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.

Authors:  S J Urbanski; D R Edwards; N Hershfield; S A Huchcroft; E Shaffer; L Sutherland; A E Kossakowska
Journal:  Diagn Mol Pathol       Date:  1993-06

10.  Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.

Authors:  H Sato; Y Kida; M Mai; Y Endo; T Sasaki; J Tanaka; M Seiki
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

View more
  5 in total

1.  Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.

Authors:  Roopali Roy; Gwendolyn Louis; Kevin R Loughlin; Dmitri Wiederschain; Susan M Kilroy; Carolyn C Lamb; David Zurakowski; Marsha A Moses
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

2.  Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma.

Authors:  Warner Alpízar-Alpízar; Ole Didrik Laerum; Ib J Christensen; Kjell Ovrebo; Arne Skarstein; Gunilla Høyer-Hansen; Michael Ploug; Martin Illemann
Journal:  J Histochem Cytochem       Date:  2016-07-01       Impact factor: 2.479

3.  Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.

Authors:  Ilya Ulasov; Bart Thaci; Purvaba Sarvaiya; Ruiyang Yi; Donna Guo; Brenda Auffinger; Peter Pytel; Lingjiao Zhang; Chung Kwon Kim; Anton Borovjagin; Mahua Dey; Yu Han; Anatoly Y Baryshnikov; Maciej S Lesniak
Journal:  Cancer Med       Date:  2013-06-30       Impact factor: 4.452

4.  Genome-wide Analyses on Single Disease Samples for Potential Biomarkers and Biological Features of Molecular Subtypes: A Case Study in Gastric Cancer.

Authors:  Wei Zeng; Nini Rao; Qian Li; Guangbin Wang; Dingyun Liu; Zhengwen Li; Yuntao Yang
Journal:  Int J Biol Sci       Date:  2018-05-22       Impact factor: 6.580

5.  Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer.

Authors:  Bodong Xu; Zhigang Bai; Jie Yin; Zhongtao Zhang
Journal:  PeerJ       Date:  2019-06-10       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.